Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
…
16,160$
3,46%
Echtzeit-Aktienkurs Sutro Biopharma Inc.
Bid:
Ask:
Nachrichten zur Sutro Biopharma Inc. Aktie
Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
…
Sutro Biopharma stock falls after announcing 1-for-10 reverse split By Investing.com
Sutro Biopharma stock falls after announcing 1-for-10 reverse split…
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
Sutro Biopharma (STRO) delivered earnings and revenue surprises of +64.10% and +293.54%, respectively, for the quarter ended June 2025. Do…
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates
Sutro Biopharma (STRO) delivered earnings and revenue surprises of -44.44% and 25.83%, respectively, for the quarter ended March 2025. Do…
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates
Sutro Biopharma (STRO) delivered earnings and revenue surprises of -3.49% and 34.11%, respectively, for the quarter ended December 2024. Do…
Sutro Biopharma: I Dont Buy That Their Pipeline Is Worthless
…
Sutro Biopharma stock hits 52-week low at $2.02 By Investing.com
Sutro Biopharma stock hits 52-week low at $2.02…
Sutro Biopharma (NASDAQ:STRO) shareholders have endured a 80% loss from investing in the stock three years ago
As every investor would know, not every swing hits the sweet spot. But you have a problem if you face…
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:…
Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:…
Sutro Biopharma (STRO) Rises 9% in the Past Week: Heres Why
Sutro Biopharma (STRO) gains 9% in a week after initiating a phase II study on its lead candidate, luvelta, to…
Coping with a Wild Ride: Investing in Sutro Biopharma (NASDAQ:STRO)
Short-term volatility is the hallmark of clinical-stage biopharma investing, and Sutro Biopharma (NASDAQ:STRO) is a fine example of that, recently…
Coping with a Wild Ride: Investing in Sutro Biopharma (NASDAQ:STRO)
Short-term volatility is the hallmark of clinical-stage biopharma investing, and Sutro Biopharma (NASDAQ:STRO) is a fine example of that, recently…
Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
Sutro Biopharma (STRO) delivered earnings and revenue surprises of 151.22% and 834.90%, respectively, for the quarter ended December 2023. Do…
Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
Sutro Biopharma, Inc. (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in…